ABOUT US
Prediction Biosciences is a clinical stage biotechnology company located in Lyon, one of the most dynamic and growing environments for biotech companies in Europe.
Our team
DIRECTORS
Josef O. Rettenmaier
Chairman Geschäftsführer JRS Group
Cornelius Diamond
President Prediction BioSciences
Stephan Rettenmaier
Geschäftsführer JRS Prozesstechnik
BOARD ADVISORS
David Shapiro – M.D., ChN, MRCP
Head of R&D and Chief Medical Officer, Intercept Pharmaceuticals
Executive Vice President and Chief Medical Officer, Idun Pharmaceuticals (Pfizer).
Vice President of Clinical Research, Gensia Pharmaceuticals.
Vice President and Member of the Board of Trustees and Executive Committee, American Founder, Medical Research Center of Scripps Clinic – San Diego
Manager, Hypertension Clinical Research Group Merck.
Konstantin Matentzoglu – Ph.D
Chief Executive Officer, Celonic AG
MANAGEMENT
Cornelius Diamond
President
Dr. Diamond has a Ph.D. in BioPhysics from the University of California, San Diego.
He is an inventor on a number of patents in the areas of biomarker diagnostics, computational modeling, and drug delivery, and he is the developer of the GeneRx™ platform. Dr. Diamond founded Neologic (technology sold to UBS) and previously worked for Boeing, Microsoft, and Ipitek in various technical management positions.
Dr. Albert K. Man
Director, Diagnostic Development and Commercialization
Dr. Man has a Ph.D. in Molecular Pathology from the University of California, San Diego. He previously worked at the Burnham Institute for Medical Research in La Jolla, California. Dr. Man has published articles and is an inventor on patents in the areas of cancer and hypertension. Dr. Man is the co-founder of Eolas Inc., a company developing small molecule therapeutics for addiction.
Dr. Caroline Bourgin-Hierle
Director, Research and Development
Dr Bourgin-Hierle obtained her PhD in Molecular and Cellular Biology from the University of Lyon-Claude Bernard, France. She was then a postdoctoral fellow investigating molecular mechanisms involved in neurodegenerative disorders at the Sanford-Burnham Medical Research Institute in La Jolla, CA. Dr Bourgin-Hierle published many peer-reviewed articles and today manages the R&D programs of the company and collaborations in the field of stroke and neurodegenerative diseases.
Our investors
